Reply to: "Evaluating sarcopenia in patients with cirrhosis: The role of muscle function"
- PMID: 35504442
- DOI: 10.1016/j.jhep.2022.04.023
Reply to: "Evaluating sarcopenia in patients with cirrhosis: The role of muscle function"
Conflict of interest statement
Conflict of interest FJ: Speaker: Gilead Sciences, MSD and Ascletis. Consulting or advisory board: Gilead Sciences and MSD. All other authors do not have conflict of interest. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment on
-
Evaluating sarcopenia in patients with cirrhosis: The role of muscle function.J Hepatol. 2022 Aug;77(2):564-565. doi: 10.1016/j.jhep.2022.03.020. Epub 2022 Mar 26. J Hepatol. 2022. PMID: 35351521 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources